Avalyn Pharma Inc.
NASDAQAVLN short interest falls 21% in a week as stock rallies 17% on trial data and shorts retreat.
Snapshot as of 16 Sept 2026
AVLN enters the week with a sharp disconnect between rising conviction from buyers and a short base that is quietly unwinding — while the next earnings catalyst is just three weeks away. The stock gained 15.4% over the…
Avalyn Pharma enters the second half of June with an unusual split: short sellers are piling in at the fastest pace in months, while major institutional backers are adding aggressively at lower prices. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AVLN — free to start on ORTEX.
Sign up for free →Open AVLN on ORTEX